Task: Answer the multiple choice question.
Query: Which compound exhibits a 3.447% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCOCCCNC(=O)C(c1ccc(Cl)cc1)N1CCC2(CC1)OCCO2
(b) COCCN1C(=O)C(CC(=O)Nc2ccccc2)SC1=Nc1ccc(OC)cc1
Answer: b. COCCN1C(=O)C(CC(=O)Nc2ccccc2)SC1=Nc1ccc(OC)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCN1C(=O)C(CC(=O)Nc2ccccc2)SC1=Nc1ccc(OC)cc1
COCCN1C(=O)C(CC(=O)Nc2ccccc2)SC1=Nc1ccc(OC)cc1
2-[3-(2-methoxyethyl)-2-(4-methoxyphenyl)imino-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide